Journal article

Heterogeneous copper concentrations in cancerous human prostate tissues

Delphine Denoyer, Sharnel AS Clatworthy, Shashank Masaldan, Peter M Meggyesy, Michael A Cater

PROSTATE | WILEY | Published : 2015


BACKGROUND: Therapeutics that target copper for the treatment of prostate cancer are being evaluated in human clinical trials. Elevated intracellular copper is considered to sensitize prostate cancer cells to certain copper-coordination compounds, especially those with ionophoric properties. While there is compelling in vitro evidence that prostate cancer cells accumulate intracellular copper, a corresponding status for copper in patient tissues has not been corroborated. We therefore established whether copper concentrations increase in cancerous prostate tissues, and in sera, in patients throughout disease progression. METHODS: Human prostate tissue samples were obtained from patient prost..

View full abstract

University of Melbourne Researchers